An observational study in Morbidly Adherent Placenta, sponsored by Aljazeera Hospital. Completed at 1 site in Egypt. Open to female participants aged 20 Years to 43 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-09-16.
Sponsored by Aljazeera Hospital · Observational
Placenta accreta occurs when the placental implantation is abnormal. The marked rise in incidence has been assumed the increasing prevalence of cesarean delivery in recent years.
The most accepted theory is that abnormal placentation . The most important risk factor for placenta accreta is placenta previa after a prior cesarean delivery. The first clinical manifestation of placenta accreta is usually severe , life-threatening hemorrhage. The recommended intervention of suspected placenta accreta is planned preterm cesarean hysterectomy with the placenta left in situ.
pregnant females with previous cs will be subjected to US to assess placental location and MAP
Exclusion Criteria:
TA , TV ,TP us
TA,TV.TP us
number of participants who will be diagnosed to have normal placenta or placenta previa or morbidly adherent placenta by US
Time frame: within 6 weeks
This study is completed, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Aljazeera Hospital